We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRH icon
251
CRH
CRH
$69.1B
$17.3M 0.08%
186,403
+177,411
+1,973% +$14.9M
HPQ icon
252
HP
HPQ
$25.9B
$17.2M 0.08%
480,829
+321,455
+202% +$11.3M
ARMK icon
253
Aramark
ARMK
$15.1B
$17.2M 0.08%
445,265
+10,092
+2% +$356K
GMED icon
254
Globus Medical
GMED
$10.9B
$17.2M 0.08%
240,286
-3,831
-2% -$270K
ENS icon
255
EnerSys
ENS
$6.69B
$17.1M 0.08%
167,314
-2,327
-1% -$235K
NEO icon
256
NeoGenomics
NEO
$1.74B
$17M 0.08%
1,155,439
-16,295
-1% -$255K
VBR icon
257
Vanguard Small-Cap Value ETF
VBR
$37.7B
$17M 0.08%
84,873
-96
-0.1% -$18.5K
A icon
258
Agilent Technologies
A
$39.7B
$17M 0.08%
114,638
+40,231
+54% +$5.51M
SPG icon
259
Simon Property Group
SPG
$76.8B
$17M 0.08%
100,451
+83,049
+477% +$13.1M
FL
260
DELISTED
Foot Locker
FL
$16.9M 0.08%
655,023
-9,412
-1% -$260K
SPGI icon
261
S&P Global
SPGI
$126B
$16.8M 0.08%
32,539
-1,314
-4% -$650K
SHOP icon
262
Shopify
SHOP
$169B
$16.8M 0.08%
209,581
+61,697
+42% +$4.26M
CBRE icon
263
CBRE Group
CBRE
$43.1B
$16.7M 0.08%
134,442
+5,657
+4% +$617K
SLGN icon
264
Silgan Holdings
SLGN
$5.07B
$16.7M 0.08%
318,282
-4,790
-1% -$233K
CRUS icon
265
Cirrus Logic
CRUS
$6.87B
$16.6M 0.08%
133,570
+5,251
+4% +$695K
LBRT icon
266
Liberty Energy
LBRT
$2.89B
$16.6M 0.08%
868,169
-10,948
-1% -$226K
FOXA icon
267
Fox Class A
FOXA
$24.2B
$16.5M 0.08%
389,470
+276,259
+244% +$10.7M
TOL icon
268
Toll Brothers
TOL
$14.5B
$16.5M 0.08%
106,562
+9,956
+10% +$1.35M
MSCI icon
269
MSCI
MSCI
$42.1B
$16.4M 0.08%
28,148
+9,527
+51% +$5.17M
OC icon
270
Owens Corning
OC
$11.5B
$16.4M 0.08%
92,934
+3,288
+4% +$554K
NEOG icon
271
Neogen
NEOG
$2B
$16M 0.08%
953,137
-4,068
-0.4% -$66.9K
HAYW icon
272
Hayward Holdings
HAYW
$3.28B
$15.7M 0.08%
1,026,301
-15,545
-1% -$215K
MS icon
273
Morgan Stanley
MS
$333B
$15.7M 0.08%
150,971
-1,693
-1% -$170K
STAG icon
274
STAG Industrial
STAG
$7.79B
$15.7M 0.08%
401,988
-5,011
-1% -$196K
IWD icon
275
iShares Russell 1000 Value ETF
IWD
$82.2B
$15.7M 0.07%
82,547
+1,552
+2% +$283K
9 10
11
12 13

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.